Back to results
Recruiting

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

NCT06111417

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre Georges-François Leclerc

Dijon, France

+1 additional location

Contact

Manon REDA, Dr

03.80.73.75.00mreda@cgfl.fr
View on ClinicalTrials.gov
Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners — TrialFind